Latest Investments News

QuickFee Limited reports mixed Q4 FY25 results with solid growth in US Pay Now and Australian Finance, offset by a significant US Finance decline due to credit impairment. The company completes a major refinancing and capital raise while maintaining FY25 earnings guidance.

QuickFee Limited has completed a significant A$118 million debt refinancing and successfully raised A$1.25 million through a share placement, alongside announcing a new Share Purchase Plan to support its expansion in the US and Australian markets.

Anax Metals has issued a detailed clarification on its recent $3.3 million convertible note placement with Mineral Development Partners, addressing inconsistencies in shareholder approval disclosures and announcing strengthened compliance measures.

National Storage REIT has partnered with GIC to invest $228 million in a second tranche of self-storage development assets, reaffirming its FY25 earnings guidance and strategic growth plans.

Ovanti Limited is set to raise approximately $1 million through a two-tranche share placement to support its US buy now, pay later expansion and ongoing legal matters.

Andromeda Metals has achieved a key financing milestone with Merricks Capital's credit approval of a A$75 million debt facility, advancing the Great White Project towards final investment decision.

Tivan Limited has fully redeemed its convertible notes issued to SBC Global Investment Fund ahead of schedule, marking a significant step in its financial restructuring. The company now plans to remove SBC’s security interests on its assets before the fiscal year ends.

Dominion Income Trust 1 (ASX – DN1) has announced a wholesale placement of 450,000 new units, aiming to raise $45.45 million at $101 each. The placement targets wholesale investors and supports monthly distributions with a competitive target return.

Dominion Income Trust 1 (ASX – DN1) has announced a $45 million placement at $101 per unit, aiming to enhance fund diversification and liquidity without impacting net asset value.

CZR Resources has secured Foreign Investment Review Board approval for the sale of its Robe Mesa Iron Ore Project, marking a significant step toward closing the A$75 million transaction.

Mayne Pharma rebuffs Cosette's claim of a material adverse change in their merger scheme and secures FDA clearance on regulatory concerns, maintaining its commitment to the deal's completion.

Zeta Resources has received Foreign Investment Review Board approval to increase its stake in Future Metals and has fully underwritten the company’s A$2.64 million entitlement offer, ensuring the capital raise is secured.